Amicus Therapeutics, Inc. (LON: 0HF9)
London
· Delayed Price · Currency is GBP · Price in USD 9.54
+0.02 (0.21%)
Jan 22, 2025, 3:30 PM BST
Amicus Therapeutics Market Cap
Amicus Therapeutics has a market cap or net worth of 2.31 billion as of January 23, 2025. Its market cap has decreased by -25.64% in one year.
Market Cap
2.31B
Enterprise Value
2.47B
Revenue
368.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.54
Market Cap Chart
Since May 31, 2007, Amicus Therapeutics's market cap has increased from 162.11M to 2.31B, an increase of 1,327.80%. That is a compound annual growth rate of 16.25%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.37B |
| GSK plc | 55.25B |
| Haleon | 33.81B |
| Smith & Nephew | 8.96B |
| ConvaTec Group | 4.94B |
| Hikma Pharmaceuticals | 4.62B |
| HUTCHMED (China) | 1.99B |
| Oxford Nanopore Technologies | 1.42B |